21-Nov-2026 09:36:05

COHANCEGeneral news

COHANCE : USFDA ISSUES EIR FOR SHAMSHABAD FDF FACILITY WITH VAI CLASSIFICATION

• USFDA issued the Establishment Inspection Report (EIR) for the company's formulation (FDF) manufacturing facility at Shamshabad, Telangana • Inspection outcome classified as Voluntary Action Indicated (VAI) • With receipt of the EIR, the said inspection stands concluded • Update follows the company's earlier communication dated 5 September 2026 on the USFDA inspection at the facility

Cohance Lifesciences Ltd

Open attachment

← Back to feed